Table 3.

Treatment-related adverse events (TRAEs) identified by investigators

	Grade 1		Grade 2		Grade 3		Grade 4
	No	%	No	%	No	%	No	%
All patients with an event	27	96.4	18	64.2	10	35.7	2	7.1
Anorexia	9	32.1	2	7.1	1	3.6	0	0.0
Nausea	7	25.0	1	3.6	0	0.0	0	0.0
Vomiting	1	3.6	0	0.0	0	0.0	0	0.0
Fatigue	3	10.7	0	0.0	0	0.0	0	0.0
Constipation	1	3.6	0	0.0	0	0.0	0	0.0
Diarrhea	0	0.0	1	3.6	0	0.0	0	0.0
Rash	2	7.1	0	0.0	0	0.0	0	0.0
Dizziness	1	3.6	0	0.0	0	0.0	0	0.0
Alopecia	6	21.4	9	32.1	0	0.0	0	0.0
Oral mucositis	0	0.0	1	3.6	0	0.0	0	0.0
Dermatitis radiation	1	3.6	0	0.0	0	0.0	0	0.0
White blood cell decreased	5	17.9	5	17.9	5	17.9	0	0.0
Neutropenia	7	25.0	6	21.4	6	21.4	2	7.1
Creatinine increased	5	17.9	0	0.0	0	0.0	0	0.0
Anemia	14	50.0	2	7.1	0	0.0	0	0.0
Alanine aminotransferase increased	1	3.6	0	0.0	0	0.0	0	0.0
Aspartate aminotransferase increased	1	3.6	0	0.0	0	0.0	0	0.0
Blood bilirubin increased	1	3.6	0	0.0	0	0.0	0	0.0
Hyperuricemia	6	21.4	0	0.0	0	0.0	0	0.0
Hyperglycemia	6	21.4	0	0.0	0	0.0	0	0.0